A phase I study of docetaxel plus synthetic lycopene in metastatic prostate cancer patients
Abstract Purpose Our preclinical studies showed that lycopene enhanced the anti‐prostate cancer efficacy of docetaxel in animal models. A phase I trial (NCT0149519) was conducted to identify an optimum dose of synthetic lycopene in combination with docetaxel (and androgen blockade [androgen deprivat...
Guardado en:
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Wiley
2024-03-01
|
| Colección: | Clinical and Translational Medicine |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1002/ctm2.1627 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|